← Back to Home
Intraday·Markets Desk·Today
Intraday Calls: PNBHOUSING, LAURUSLABS and 17 More in Focus
Nifty and 9 other SEBI-registered analysts issued 30 intraday recommendations across 19 stocks for single-session action, with a broadly bullish bias.
By Markets Desk·30 Calls·24 Buy, 6 Sell
Nifty and 9 other SEBI-registered analysts issued 30 equity intraday recommendations today, targeting single-session price action before market close at 3:30 PM IST. The batch carries a broadly bullish bias — 24 buys against 6 sells — covering 19 stocks.
The 5 most-covered names of the session:
PNBHOUSING drew 6 calls — 6 sell calls — from Nifty, with entries between ₹1,127 and ₹1,142 and targets between ₹1,111 and ₹1,132.
LAURUSLABS attracted 3 separate recommendations from 2 SEBI-registered analysts — KotakSecurities (SEBI Reg. INH000000586) issued 2 buys at ₹2,010 targeting ₹2,060 and ₹2,040 (stop ₹1,896); Prudentbroking (SEBI Reg. INH000018115) issued a buy at ₹1,994, targeting ₹2,100 (stop ₹1,942).
APOLLOHOSP attracted 2 buys from KotakSecurities (SEBI Reg. INH000000586) at ₹8,950.5 targeting ₹9,085 and ₹9,175 (stop ₹8,845).
DELHIVERY attracted 2 buys from Jainamresearch (SEBI Reg. INH000006448) — a buy at ₹435.45, a buy at ₹436 targeting ₹444 (stop ₹431.3).
EDELWEISS attracted 2 buys from Siddharth Ray Mangla (SEBI Reg. INH000024693) at ₹136 targeting ₹142 and ₹144 (stop ₹134).
The remaining 14 stocks covered by SEBI-registered analysts, with the price at which each call was issued:
Buy calls — GRASIM (₹3,188 → ₹3,910) via Jefferies; AARTIIND (₹496 → ₹506) via Prudentbroking; BUILDPRO (₹430 → ₹437) via Integratedresearchchannel; DRREDDY (₹1,198.9 → ₹1,205.8) via Integratedresearchchannel; ENGINERSIN (₹273.5 → ₹280) via Prudentbroking; HDFCBANK (₹741 → ₹1,000) via UBS; INDIGO (₹4,982 → ₹5,840) via Jefferies; INOXWIND (₹76.6 → ₹78.5) via Prudentbroking.
MAXHEALTH (₹1,066 → ₹1,086) via Prudentbroking; MOTHERSON (₹162 → ₹168.5) via Manas Jaiswal; PPLPHARMA (₹213.6 → ₹225) via Prudentbroking; SOLARINDS (₹19,100 → ₹19,300) via Jainamresearch; TECHM (₹1,544.9 → ₹1,554.3) via Integratedresearchchannel; TORNTPHARM (₹4,952 → ₹5,200) via Somil Mehta.
This roundup reproduces calls from 10 SEBI-registered Research Analysts: Nifty (SEBI Reg. INH000017125); Prudentbroking (SEBI Reg. INH000018115); KotakSecurities (SEBI Reg. INH000000586); Integratedresearchchannel (SEBI Reg. INH200006530); Jainamresearch (SEBI Reg. INH000006448); Jefferies (SEBI Reg. INH000000701); Siddharth Ray Mangla (SEBI Reg. INH000024693); Manas Jaiswal (SEBI Reg. INH100001625); Somil Mehta (SEBI Reg. INH000006183); UBS (SEBI Reg. INH000001204).
Intraday calls carry elevated risk and require active monitoring. All positions should be squared off before 3:30 PM IST unless the issuing analyst specifies otherwise.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
SEBI-Registered Research Analysts
Nifty · SEBI Reg. INH000017125Prudentbroking · SEBI Reg. INH000018115KotakSecurities · SEBI Reg. INH000000586Integratedresearchchannel · SEBI Reg. INH200006530Jainamresearch · SEBI Reg. INH000006448Jefferies · SEBI Reg. INH000000701Siddharth Ray Mangla · SEBI Reg. INH000024693Manas Jaiswal · SEBI Reg. INH100001625Somil Mehta · SEBI Reg. INH000006183UBS · SEBI Reg. INH000001204
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.